We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance Formed to Introduce Proton Therapy in India

By HospiMedica International staff writers
Posted on 29 Jun 2015
Ion Beam Applications (IBA; Louvain-La-Neuve, Belgium) and Philips India (Gurgaon, India) have signed an exclusive alliance to enhance access to proton therapy in India.

The exclusive agreement between IBA, the world's leading provider of proton therapy solutions for cancer treatment, and Philips, a leading provider of image-guided therapy, and clinical informatics/imaging technology, follows the framework agreement the two companies signed in September, 2014.

The two companies will focus on improving the diagnosis and treatment of cancer in India, and reducing side-effects of treatment. More...


The incidence of cancer in India is 70–90 per 100,000 people, including nearly 5% children. Proton therapy is especially effective for the treatment of pediatric cancers, and tumors of the eye, brain, prostate, liver, lungs, and tumors close to the spinal cord, or brain stem.

Mr. Sameer Garde, president, Philips Healthcare, said, "We are very pleased to announce that Philips India and IBA are introducing the best-in-class proton beam therapy for cancer patients in India. We are confident that the future launch of the first proton therapy center in Apollo Hospitals, Chennai, will mark the beginning of a new phase in cancer treatment in the country and also the subcontinent".

Related Links:

IBA
Philips India 



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Tourniquet System
heidi– mein Tourniquet
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.